<DOC>
	<DOC>NCT02984722</DOC>
	<brief_summary>The aim of our study is to compare the different effects of 6 months treatment with extended-release metformin and immediate-release metformin on clinical, endocrine and metabolic parameters in women affected by polycystic ovary syndrome. We also evaluate gastrointestinal disorders associated with the two different compouds.</brief_summary>
	<brief_title>Extended-release vs Immediate-release Metformin in PCOS Women</brief_title>
	<detailed_description />
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>women with PCOS in accordance with Rotterdam criteria pregnancy diabetes mellitus (or impaired glucose tolerance as determined by a standard 75 gr oral glucose tolerance test) past history of cardiovascular diseases past history of gastrointestinal diseases significant liver or renal dysfunction (hypothalamic, pituitary, thiroidal or adrenal); neoplasms.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>PCOS</keyword>
	<keyword>metformin</keyword>
</DOC>